PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of springeropenLink to Publisher's site
Basic Research in Cardiology
 
Basic Res Cardiol. 2010 November; 105(6): 771–785.
Published online 2010 October 20. doi:  10.1007/s00395-010-0124-1
PMCID: PMC2978889

Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion

Abstract

The signal transducer and activator of transcription 3 (STAT3) contributes to cardioprotection by ischemic pre- and postconditioning. Mitochondria are central elements of cardioprotective signaling, most likely by delaying mitochondrial permeability transition pore (MPTP) opening, and STAT3 has recently been identified in mitochondria. We now characterized the mitochondrial localization of STAT3 and its impact on respiration and MPTP opening. STAT3 was mainly present in the matrix of subsarcolemmal and interfibrillar cardiomyocyte mitochondria. STAT1, but not STAT5 was also detected in mitochondria under physiological conditions. ADP-stimulated respiration was reduced in mitochondria from mice with a cardiomyocyte-specific deletion of STAT3 (STAT3-KO) versus wildtypes and in rat mitochondria treated with the STAT3 inhibitor Stattic (STAT3 inhibitory compound, 6-Nitrobenzo[b]thiophene 1,1-dioxide). Mitochondria from STAT3-KO mice and Stattic-treated rat mitochondria tolerated less calcium until MPTP opening occurred. STAT3 co-immunoprecipitated with cyclophilin D, the target of the cardioprotective agent and MPTP inhibitor cyclosporine A (CsA). However, CsA reduced infarct size to a similar extent in wildtype and STAT3-KO mice in vivo. Thus, STAT3 possibly contributes to cardioprotection by stimulation of respiration and inhibition of MPTP opening.

Keywords: Cardioprotection, Ischemia, Mitochondrial permeability transition pore, Mitochondrion, Reperfusion, STAT

Introduction

Signal transducer and activator of transcription (STAT) proteins transduce stress signals from the plasma membrane to the nucleus, thereby acting as signaling molecules and transcriptional regulators [4]. Several STAT proteins are expressed in the heart, among them are STAT1, 3, and 5. Even though STAT proteins are highly homologous, their functions differ substantially, notably in ischemia/reperfusion: STAT1 enhances whereas STAT3 and STAT5 reduce cardiomyocyte death [4, 23].

STAT3 and 5 are involved in the reduction of myocardial injury by ischemic pre- and postconditioning [10, 24, 39, 43], i.e. endogenous cardioprotective phenomena which have been identified in all species so far, including man [17, 28, 42]. Deletion of STAT3 (STAT3-KO) or STAT5 abolishes the infarct size reduction by ischemic preconditioning in mice hearts [41, 46]; the infarct size reduction by ischemic postconditioning is also attenuated in STAT3-KO mice [2, 22].

Since the cardioprotection by classical ischemic pre- and postconditioning is not dependent on increased mRNA levels [26, 38], it is unlikely that STATs exert their protective effect via regulation of target gene transcription [14], although increased nuclear translocation and DNA-binding of STAT1 and STAT3 have been observed with ischemic preconditioning [45, 46].

Mitochondria are centrally involved in the signal transduction of ischemic pre- and postconditioning [18]. Opening of the mitochondrial permeability transition pore (MPTP) is a major determinant of cardiomyocyte death and inhibition of MPTP opening is central to protection by ischemic pre- and postconditioning [8, 15, 21], most likely also in humans [32]. Recently, STAT3 was identified in mouse cardiomyocyte mitochondria, where it regulates complex I activity and oxygen consumption [44]. The present study confirms these findings and extends them to further address (1) the presence of STATs in subsarcolemmal (SSM) and interfibrillar (IFM) mitochondria [7, 29, 35]; (2) the interaction of STAT3 with mitochondrial respiration and MPTP opening; (3) the interaction of STAT3 with other proteins; and finally (4) the importance of STAT3 for cardioprotective strategies.

Materials and methods

The present study was performed with approval by the Bioethical Committee of the State of Nordrhein-Westfalen, Germany. It conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication No. 85-23, revised 1996).

In the present study, female mice with a cardiomyocyte-restricted deletion of STAT3 (STAT3-KO), which were generated by breeding STAT3-floxed mice (STAT3flox/flox) with α-myosin heavy chain promoter/Cre recombinase transgenic mice (αMHC-Cretg/−) [20] and their wild type (WT) littermates, male and female young (8 weeks, 9 females, 1 male) and aged (21 months, 9 females, 2 males) mice (C57/Bl6 background) and 3-month-old Lewis rats were studied.

Mitochondria isolation

For respiration and calcium handling, subfractionation, immunoprecipitation, western blot analysis, and confocal laser scan microscopy, subsarcolemmal mitochondria (SSM) were isolated, as described previously [3]. In brief, left ventricular (LV) tissue was minced in isolation buffer (in mmol/L: sucrose 250; HEPES 10; EGTA 1, pH 7.4). The LVs were homogenized (Ultra Turrax, 3 steps of ~5 s each, low speed) and then centrifuged at 600g for 10 min. The supernatant was centrifuged at 10,780g for 10 min. The resulting sediment was resuspended in isolation buffer and centrifuged at 7,650g for 10 min. To analyze STAT1 and STAT3 content in SSM and interfibrillar mitochondria (IFM), SSM and IFM were isolated from rat ventricles, as previously described [7]. For mitochondrial subfractionation, immunoprecipitation, and western blot analysis, mitochondria were further purified by percoll-gradient ultracentrifugation. Mitochondria were layered on top of a 30% percoll solution in isolation buffer and centrifuged at 35,000g for 30 min. The lower mitochondrial band was collected and washed twice in isolation buffer by centrifugation at 8,000g for 5 min.

Pharmacological inhibition of STAT3

Rat LV SSM were incubated with 100 μmol/L Stattic (STAT3 inhibitory compound, 6-Nitrobenzo[b]thiophene 1,1-dioxide), a concentration previously shown to reduce STAT3 phosphorylation in isolated mouse hearts [11], or DMSO as vehicle for 1 h at 4°C and subsequently analyzed for STAT3 phosphorylation at tyrosine 705 and serine 727 by immunoprecipitation (percoll-purified mitochondria). Non-purified mitochondria were used to study mitochondrial oxygen consumption and calcium-induced MPTP opening.

Mitochondrial function

The respiration of 0.1 mg/mL SSM proteins was measured in a Clark-type oxygen electrode (Strathkelvin, Glasgow, UK) at 25°C in incubation buffer using 5 mmol/L glutamate and 2.5 mmol/L malate as substrates for complex 1 or 5 mmol/L succinate (in combination with 2 μmol/L rotenone to inhibit complex 1) as substrate for complex 2. After recording of basal oxygen consumption, respiration was determined after the addition of 40 μmol/L ADP [7]. Complex 4 respiration was determined after the addition of 1.8 μM antimycin A to inhibit complex 3 and 300 μM TMPD (N,N,N′,N′-tetramethyl-p-phenylenediamine) and 3 mM ascorbate—which donates electrons to cytochrome oxidase via the reduction of cytochrome c. Maximal respiration was determined after the subsequent addition of 1.3 μmol/L oligomycin to inhibit the ATP synthase and 30 nmol/L FCCP.

Calcium retention capacities of 0.1 mg/mL rat SSM or 0.075 mg/mL mouse SSM were measured in 2 ml incubation buffer without EGTA at 25°C using 5 mmol/L glutamate and 2.5 mmol/L malate as substrates for complex 1 or 5 mmol/L succinate with 2 μmol/L rotenone as substrate for complex 2. Extramitochondrial calcium was detected using 0.5 μmol/L calcium green 5 N (Invitrogen, Carlsbad, CA, USA) with a Cary Eclipse spectrophotometer at excitation and emission wavelengths of 500 and 530 nm, respectively. Experiments were performed in the presence and absence of 40 μmol/L ADP and 1.2 mmol/L MgCl2. Six nmol (mouse SSM without ADP and MgCl2) or 10 nmol (all other groups) CaCl2 were added once per minute until an increase in calcium green fluorescence was detected, reflecting MPTP opening.

Subfractionation of mitochondria

Mitochondria were subfractionated following a modified protocol [36]. Freshly isolated percoll-purified rat LV SSM were resuspended in 150 mmol/L KCl supplemented with 100 μM digitonin and protease inhibitors (Complete, Roche, Basel, Switzerland). After incubation for 10 min on ice, the mitochondria were centrifuged at 10,000g for 10 min at 4°C. The supernatant contained the proteins of the intermembrane space. The sediment was resuspended in isolation buffer supplemented with 200 μmol/L digitonin. An equal volume of sunflower oil was added, and the mitochondria were vigorously mixed for 5 min. After centrifugation for 5 min at 14,000g, the lower phase containing the matrix was separated from the interphase containing the membrane proteins.

Mitochondrial swelling was induced by incubation in hypoosmotic solution (5 mmol/L sucrose, 5 mmol/L Hepes, 1 mmol/L EGTA, pH 7.2) for 10 min before normalizing the osmolarity by adding hyperosmotic solution [37].

Immunoprecipitation and western blot analysis

Mitochondria or right ventricles were lysed in 1× Cell lysis buffer [Cell Signaling, Beverly, MA, USA; containing in mmol/L: Tris (pH 7.5) 20, NaCl 150, EDTA 1, EGTA 1, sodium pyrophosphate 2.5, β-glycerolphosphate 1, Na3VO4 1, Triton X-100 1%, Leupeptin 1 μg/mL, supplemented with 1× Complete Protease Inhibitor Cocktail (Roche, Basel, Switzerland)], and subsequently centrifuged at 13,000g for 10 min. The protein concentration of the supernatant was determined using the Dc protein assay (BioRad, Hercules, CA, USA).

For immunoprecipitation, 400 μg rat mitochondrial proteins were incubated with antibodies against total or phosphorylated STAT3 (Tyr705 or Ser727), Tom20, anti-rabbit or anti-mouse horseradish peroxidase conjugated IgGs for 1 h at 4°C. Protein A Agarose (Santa Cruz) was added to each sample followed by overnight incubation at 4°C. Protein A Agarose beads were washed three times with 500 μl PBS supplemented with 1× Complete Protease Inhibitors. After adding sample buffer, the samples were boiled for 5 min at 95°C.

Immunoprecipitated proteins, 5 μg subfractionated mitochondrial proteins or 25 μg total mitochondrial or right ventricular proteins were electrophoretically separated on 10% SDS gels and transferred to nitrocellulose membranes. Protein transfer was controlled by staining of membranes with Ponceau S. After blocking, the membranes were incubated with primary antibodies and then washed with the respective secondary antibodies. Immunoreactivities were detected using the SuperSignal West Femto Maximum Sensitivity Substrate (Pierce, Rockford, IL, USA) and densitometrically quantified with Scion Image software (Frederick, ML, USA).

Ischemia/reperfusion injury in vivo

Female STAT3-KO mice or their WT littermates were anesthetized with pentobarbital sodium (80 mg/kg ip). The temperature of the animals was kept stable between 36.6 and 37.4°C using heating pads, and the electrocardiogram was monitored continuously. After intubation (polyethylene-60 tubing), the animals were ventilated with a stroke rate of 130/min and a tidal volume of 1 mL. A midline thoracotomy and pericardiotomy were performed. The left anterior descending coronary artery (LAD) was occluded 2–3 mm distal to the tip of the left auricle using a 7.0 silk suture and a small tube to form a snare for 30 min. 5 min before reperfusion, 10 mg/kg cyclosporine A or 0.9% NaCl as vehicle were administered intravenously. Hearts were then reperfused for 120 min. 1 U/g heparin was given intraperitoneally 20 min before the end of reperfusion. At the end of the protocol, the LAD was re-occluded, 1 mL of 5% Evans Blue was injected into the left ventricle (LV), and mice were killed with a KCl bolus. Hearts were excised, and atrial and right ventricular tissues were removed. LV tissue was washed, frozen for 30 min at −20°C, cut into 5–6 transverse slices, and incubated for 20 min at 37°C in 2% TTC (2,3,5-triphenyl tetrazolium chloride) and for 12 h in 10% formalin. Tissue sections were photographed and infarct size was calculated as percent of the area at risk by planimetry.

Antibodies

The following antibodies were used in the present study: rabbit polyclonal anti-mouse phosphorylated STAT3 (Tyr705, Cell Signaling, Beverly, MA, USA), rabbit polyclonal anti-mouse phosphorylated STAT3 (Ser727, Cell Signaling, Beverly, MA, USA), rabbit polyclonal anti-mouse total STAT3 (Cell Signaling, Beverly, MA, USA), mouse monoclonal anti-mouse total STAT3 (Cell Signaling, Beverly, MA, USA), rabbit polyclonal anti-rat total connexin43 (Invitrogen, Carlsbad, CA, USA), mouse monoclonal anti-rat sodium/potassium (Na+/K+)-ATPase (Upstate, Waltham, MA, USA), mouse monoclonal anti-dog sarcoplasmic calcium (SERCA2)-ATPase (Sigma, Saint Louis, MO, USA), rabbit monoclonal anti-human histone deacetylase 2 (HDAC2, Abcam, Cambridge, UK), mouse monoclonal anti-rabbit GAPDH (Hytest, Turku, Finland), rabbit polyclonal anti-human translocase of the outer membrane 20 (Tom20, Santa Cruz, Santa Cruz, CA, USA), rabbit polyclonal anti-human VDAC (voltage-dependent anion channel, Abcam, Cambridge, UK), mouse monoclonal anti-human ATP synthase α (BD Transduction, San Diego, CA, USA), mouse monoclonal anti-rat cytochrome c (Santa Cruz, Santa Cruz, CA, USA), rabbit polyclonal anti-human cyclophilin D (Acris, Hiddenhausen, Germany), rabbit polyclonal anti-human MnSOD (manganese superoxide dismutase, Upstate, Lake Placid, NY, USA), or mouse monoclonal anti-rat cyclophilin D (MitoSciences, Eugene, OR, USA).

Statistics

Data are presented as mean values ± SEM. Western blot data of subfractionated mitochondria and infarct size data were compared by two-way repeated measures ANOVA and Fisher’s LSD. Western blot data on the expression and phosphorylation level of STAT1, STAT3, and Tom20 in SSM/IFM and on STAT3 or Cx43 in young/aged mitochondria, as well as data on mitochondrial respiration were compared by unpaired Student’s t test. A p < 0.05 indicated a significant difference.

Results

The mitochondrial preparations used to study the presence of STAT proteins were not contaminated, since western blot analysis on different amounts (2–30 μg) of rat LV SSM proteins was negative for marker proteins of the sarcolemma (Na+/K+-ATPase), sarcoplasmic reticulum (sarcoplasmic/endoplasmic reticulum calcium ATPase 2a, Serca2a), cytosol (glycerolaldehyde-3-phosphate dehydrogenase, GAPDH), nucleus (histone deacetylase 2, HDAC2), but positive for the mitochondrial markers voltage-dependent anion channel (VDAC) and ATP synthase α. In rat LV mitochondria, both STAT1 and STAT3 were detected, whereas STAT5 immunoreactivity was absent (Fig. 1a). The amounts of STAT1 and STAT3 were similar in both, the SSM and IFM populations (Fig. 1c, d). In mitochondria isolated from STAT3-KO mice, STAT3-specific immunoreactivity was largely reduced, whereas STAT1 immunoreactivity was preserved (Fig. 1b). The presence of STAT3 in WT mitochondria and the loss of STAT3 immunoreactivity in STAT3-KO mitochondria were confirmed by confocal laser scan microscopy (Appendix Fig. 9).

Fig. 1
STAT1 and 3 are present in LV mitochondria. a Western blot analysis was performed for STAT1, 3, and 5 and marker proteins of subcellular compartments (Na+/K+-ATPase: sarcolemma, Serca2a: sarcoplasmic reticulum, HDAC2: nucleus, GAPDH: cytosol, ATP synthase ...
Fig. 9
Total and phosphorylated STAT3 are present in mouse left ventricular (LV) mitochondria. a LV subsarcolemmal mitochondria (SSM) of WT (n = 6) and STAT3-KO mice (n = 8) were stained with antibodies against STAT3 (green) and ...

Since only STAT3 and STAT5 have an established role in endogenous cardioprotection, but only STAT3 is present in mitochondria, we subsequently focussed our investigations on mitochondrial STAT3.

Mitochondrial STAT3 was dually phosphorylated at tyrosine 705 and serine 727, as shown by immunoprecipitation and subsequent western blot analysis (Fig. 2b) as well as by confocal laser scan microscopy (Appendix Figs. 9 and and10).10). In STAT3-KO mitochondria, no signal for STAT3 phosphorylated at Ser727 and for STAT3 phosphorylated at Tyr705 was detected (Appendix Fig. 9).

Fig. 2
Identification of mitochondrial proteins which co-immunoprecipitate with STAT3 and characterization of the dual mitochondrial STAT3 phosphorylation. Total STAT3 was immunoprecipitated from rat LV SSM. The specificity of the immunoprecipitation is indicated ...
Fig. 10
Mitochondrial STAT3 is phosphorylated. a Subsarcolemmal mitochondria (SSM) from the rat LV were stained with antibodies against STAT3 phosphorylated at Tyr705 or Ser727 (green) and the mitochondrial marker ATP synthase α (red) and were analyzed ...

Total STAT3 was immunoprecipitated from rat LV SSM. The specificity of the immunoprecipitation was demonstrated by the lack of STAT3 immunoreactivity in the control IgG precipitation and lack of manganese superoxide dismutase (MnSOD) and cytochrome c signals in the STAT3 precipitation (Fig. 2a). Both serine-phosphorylated and total STAT3 co-immunoprecipitated with the presequence receptor Tom20 (translocase of the outer membrane 20), which is part of the mitochondrial import machinery, in rat LV protein extracts (Fig. 2c). Also, mitochondrial STAT3 co-immunoprecipitated with cyclophilin D, which is involved in the regulation of MPTP opening (Fig. 2d).

The submitochondrial localization of STAT3 was analyzed by western blot on rat LV SSM subfractionated into proteins of the intermembrane space, the inner and outer membrane, and the matrix. The matrix was not contaminated with marker proteins of the intermembrane space (cytochrome c), outer or inner membrane (VDAC or ATP synthase α, respectively), but was positive for the marker protein cyclophilin D and for STAT3 (Figs. 3a, b). The presence of STAT3 in the mitochondrial matrix was confirmed by confocal laser scan microscopy (Appendix Fig. 11). When mitochondrial swelling was induced by incubating the mitochondria in hypoosmotic buffer, immunoreactivities of marker proteins of the mitochondrial intermembrane space (adenylate kinase 2 (AK2), cytochrome c) were reduced, whereas STAT3 signal intensity was unchanged (Fig. 3c). These data were confirmed by confocal laser scan microscopy showing that 80 ± 3% of control mitochondria (as identified by MnSOD immunoreactivity, matrix marker protein) and 77 ± 4% of swollen mitochondria were positive for STAT3, whereas the number of AK2-positive mitochondria was reduced from 38 ± 4% in control mitochondria to 7 ± 1% in swollen mitochondria (n = 3, p < 0.05).

Fig. 3
STAT3 is present in the mitochondrial matrix. a Rat LV SSM were subfractionated into the proteins of the intermembrane space, the matrix, and the inner and outer membrane (membranes). Western blot analysis was performed for STAT3 and marker proteins of ...
Fig. 11
STAT3 is present in the matrix of left ventricular (LV) subsarcolemmal mitochondria (SSM). a LV rat SSM (untreated or treated with digitonin and KCl in order to remove proteins from the outer membrane and the intermembrane space) were stained with antibodies ...

In order to characterize the function of mitochondrial STAT3, mitochondrial oxygen consumption was measured. Supporting prior data [44], ADP-stimulated respiration was reduced in STAT3-KO mitochondria using substrates for complex 1. However, no significant differences were found when using complex 2 substrates (Fig. 4), and when measuring complex 4-mediated respiration (in nmol O2 min−1 mg−1protein, STAT3-KO: 385 ± 22, n = 12 vs. WT: 426 ± 23, n = 12, p = ns), or uncoupled respiration (STAT3-KO: 362 ± 29, n = 12 vs. WT: 401 ± 30, n = 12, p = ns).

Fig. 4
Genetic reduction of STAT3 decreases mitochondrial ADP-stimulated oxygen consumption. Oxygen consumption of WT (n = 12) and STAT3-KO (n = 12) SSM was measured under basal conditions and after addition of 40 μmol/L ...

Incubation of isolated rat SSM with 100 μmol/L of the STAT3-specific inhibitor Stattic significantly decreased the phosphorylation of STAT3 at Tyr705 and also tended to decrease the phosphorylation of STAT3 at Ser727 (Fig. 5a, b). Neither 100 nor 200 μmol/L of the STAT3-specific inhibitor Stattic affected mitochondrial autofluorescence or membrane potential, indicating that Stattic had no acute toxic effect on mitochondria (Appendix Fig. 12). Stattic did not impact on basal respiration using substrates for complex 1 or 2, but decreased ADP-stimulated respiration for complex 1 and—to a lesser extent—also for complex 2 (Fig. 5c, d).

Fig. 5
Pharmacological inhibition of STAT3 decreases mitochondrial ADP-stimulated oxygen consumption. a Total STAT3 was immunoprecipitated from purified rat LV SSM which were incubated with 100 μmol/L Stattic or DMSO. Western blot analysis was ...
Fig. 12
Stattic causes no acute toxic effects on mitochondria. a NAD(P)H autofluorescence of 0.5 mg/mL rat left ventricular (LV) subsarcolemmal mitochondria (SSM) was measured before and after the addition of 100 or 200 μmol/L Stattic ...

Calcium-induced MPTP opening was measured by calcium green 5 N. The calcium concentration which induced MPTP opening was similar in mitochondria from WT and STAT3-KO mice under basal conditions (no ADP and MgCl2) with complex 1 substrates (Fig. 6a). In contrast, in the presence of ADP and MgCl2, mimicking more closely the physiological situation, STAT3-KO mitochondria tolerated less calcium until MPTP opening occurred (Fig. 6b). Binding of cyclosporine A (CsA) to cyclophilin D delayed MPTP opening compared to control conditions, again, in the presence of ADP and MgCl2. The STAT3 inhibitor Stattic accelerated calcium-induced MPTP opening in rat mitochondria incubated with substrates for complex 1 even in the absence of ADP and MgCl2, and this effect was enhanced in the presence of ADP (Figs. 6c, d). CsA delayed MPTP opening to a lesser extent in Stattic-treated than in DMSO-treated mitochondria. In STAT3-KO mitochondria, Stattic did not alter calcium-induced MPTP opening in the absence of ADP (in nmol CaCl2/mg protein, DMSO: 726.5 ± 16.1; Stattic: 713.5 ± 24.0, n = 6, p = ns), thereby excluding unspecific effects of Stattic on MPTP opening.

Fig. 6
Genetic reduction and pharmacological inhibition of STAT3 enhance calcium-induced MPTP opening. The calcium concentration at which opening of the MPTP occurred (increase in calcium green 5N fluorescence) was calculated in STAT3-KO or WT mouse SSM in the ...

Using substrates for complex 2, MPTP opening in the presence of ADP and MgCl2 was induced at similar calcium concentrations in WT and STAT3-KO mitochondria (in nmol CaCl2/mg protein, WT: 1,164 ± 47, n = 7 vs. STAT3-KO: 1,264 ± 56, n = 7, p = ns). However, Stattic treatment of rat mitochondria again accelerated MPTP opening (in nmol CaCl2/mg protein, DMSO: 1,357 ± 67, n = 7 vs. Stattic: 629 ± 39, n = 7, p < 0.05).

Since STAT3 co-immunoprecipitated with cyclophilin D and cyclophilin D inhibition with CsA delayed MPTP more effectively in control than in STAT3-KO or Stattic-treated mitochondria, we studied the effects of CsA on ischemia/reperfusion injury in WT and STAT3-KO hearts in vivo. The area at risk (as percentage of the LV) was not different between groups (WT + NaCl: 25.5 ± 1.8%, n = 7; STAT3 KO + NaCl: 31.1 ± 1.5%, n = 7; WT + CsA: 25.4 ± 2.2, n = 10; STAT3 KO + CsA: 25.6 ± 1.1, n = 7, p = ns). CsA reduced infarct size after 30 min ischemia and 120 min reperfusion to a similar extent in WT and in STAT3-KO hearts in vivo (Fig. 7). Comparison with historical data [2] demonstrated that CsA and ischemic postconditioning induced infarct size reduction of similar magnitude in WT mice, whereas the cardioprotection by ischemic postconditioning, but not by CsA was lost in STAT3-KO mice.

Fig. 7
STAT3 is important for infarct size reduction by ischemic postconditioning, but not for pharmacological postconditioning with cyclosporine A (CsA). a Infarct size (in % of the area at risk) was determined in WT and STAT3-KO mice undergoing 30 min ...

We have reported a decrease of STAT3 in RV total protein extracts from aged WT mice before [2, 5]. In the present study, a reduced STAT3 protein level was also seen in mitochondria isolated from LV tissue of aged mice (Fig. 8). As positive control served the decreased level of connexin 43 in aged mitochondria, which we have also described before [5]. In contrast, the mitochondrial content of ATP synthase α was not reduced with age.

Fig. 8
Mitochondrial STAT3 content is reduced in aged mouse hearts. Western blot analysis was performed for STAT3 on LV SSM from young (8 weeks) and aged (21 months) wildtype mice. As positive control served the reduced mitochondrial content ...

Discussion

The present study demonstrates the presence of STAT1 and STAT3, but not of STAT5 in cardiomyocyte mitochondria. Our data confirm the previously described localization of STAT3 in cardiomyocyte mitochondria [44] and extend these prior data in that the mitochondrial localization of STAT proteins is not restricted to STAT3 but also true for STAT1. The lack of STAT5 in cardiomyocyte mitochondria under basal conditions does not exclude a possible mitochondrial import of STAT5 following ischemia/reperfusion; alternatively, the STAT5-mediated cardioprotection by ischemic preconditioning [46] works independently from mitochondrial signal transduction cascades.

In the present study, STAT1 and STAT3 were found in SSM and IFM, mitochondrial populations which differ in their protein composition as well as in their respiratory function and calcium retention capacity [7, 29, 35]. Therefore, the opposing roles of STAT1 and STAT3 in myocardial ischemia/reperfusion—STAT1 is associated with enhanced and STAT3 with reduced cardiomyocyte death after ischemia/reperfusion (for review see [4])—cannot be attributed to diverging localizations in mitochondrial subpopulations under physiological conditions. However, whether or not the distribution of STAT1 and STAT3 in mitochondrial subpopulations is changed after ischemia/reperfusion is currently unknown. The residual STAT3 immunoreactivity detected by western blot analysis in mitochondria from STAT3-KO hearts is presumably due to the presence of mitochondria from endothelial cells or smooth muscle cells—i.e. other STAT3 expressing cell types in the heart which are not affected by the cardiomyocyte-specific STAT3 knockout, but are included in the mitochondrial preparation.

STAT3 is encoded in the nucleus and therefore has to be imported into the mitochondria. Both phosphorylated and total STAT3 co-immunoprecipitated with the mitochondrial presequence receptor Tom20, suggesting an import of STAT3 via a Tom20-dependent pathway.

The transcriptional activity of STAT3 is regulated by post-translational modification, i.e. phosphorylation and dephosphorylation. Two major phosphorylation sites are known: phosphorylation at tyrosine 705 via Janus kinases which induces dimerization and translocation into the nucleus, and phosphorylation at serine 727 which plays a role in modulating transcriptional activity [25]. Mitochondrial STAT3 was phosphorylated at both tyrosine 705 and serine 727. The phosphorylation of STAT3 at serine 727 appears to be more pronounced. Our data do not allow to distinguish whether or not STAT3 is phosphorylated prior to its import or within the mitochondria. Subfractionated mitochondria were characterized to identify the submitochondrial localization of STAT3, and STAT3 was predominantly detected in the mitochondrial matrix. However, the degree of phosphorylation of STAT3 in different mitochondrial compartments remains unclear. Our data are in accordance to and extend the data by Wegrzyn et al. [44], who have previously excluded the presence of STAT3 in the outer membrane of liver mitochondria. STAT3 as a transcriptional activator in the mitochondrial matrix may influence the transcription of genes encoded in the chondriome. However, Wegrzyn et al. [44] found no differences in the transcript levels of mitochondrially encoded genes in wildtype and STAT3-deficient pro-B cells. These results suggest that mitochondrial STAT3 serves a function different from transcriptional activation. Previous data propose that the serine 727 phosphorylation is important for the effect of STAT3 on mitochondrial respiratory complex 1 and 2 activities [27, 44].

In the present study, mitochondria isolated from STAT3-KO hearts had reduced ADP-stimulated complex 1 respiration compared to mitochondria isolated from WT hearts, confirming previous results [44]. However, when measuring complex 2- or complex 4-mediated respiration and uncoupled respiration, only a trend towards a decreased ADP-stimulated respiration was detected. STAT3-deficiency was associated with decreased complex 5 activity and reduced ATP contents in H-RasV12-transformed cells [12]; however, the present study did not characterize complex 5 activity and ATP-production of isolated cardiomyocyte mitochondria.

The investigation of mitochondria isolated from STAT3-KO hearts does not allow to distinguish whether the effects of STAT3 on respiration are caused directly by mitochondrial STAT3 or indirectly by changing the transcription of nuclear-encoded mitochondrial target genes. We therefore also studied respiration in rat mitochondria, which were incubated with the STAT3-specific inhibitor Stattic. The concentration of 100 μmol/L Stattic has previously been shown to effectively reduce the tyrosine phosphorylation of STAT3 in isolated mouse hearts [11]. In the present study, Stattic also decreased mitochondrial STAT3 tyrosine 705 and tended to reduce STAT3 serine 727 phosphorylation. In Stattic-treated mitochondria, ADP-stimulated complex 1 respiration was reduced to about 50% of control. Using complex 2 substrates, Stattic reduced ADP-stimulated respiration again to a lesser extent than with complex 1 substrates. Taken together, genetic reduction and pharmacological inhibition of STAT3 did not alter basal respiration, but decreased ADP-stimulated respiration, notably that of complex 1. Whereas STAT3 has been demonstrated to be associated with complex 1 and possibly with complex 2 [44], a recent study calculated the ratio of complexes 1 and 2 over STAT3 to be in the order of 105 [31], making a direct protein–protein interaction between STAT3 and complexes 1 and 2 unlikely. However, STAT3 may influence respiration indirectly via modulation of the activity of protein kinases, e.g. by facilitating the docking of kinases to target proteins [30].

The MPTP, a voltage-dependent, high conductance mitochondrial membrane channel, opens when exposed to high concentrations of reactive oxygen species and calcium at normal intracellular pH. The well-established inhibitory effects of ADP and MgCl2 on calcium-induced MPTP opening [9, 34] were confirmed in the present study, since the amounts of calcium needed to induce MPTP opening were higher in the presence of ADP and MgCl2. Opening of the MPTP releases cytochrome c and induces cardiomyocyte apoptosis and necrosis. Inhibition of MPTP opening is important for cardiomyocyte survival and the cardioprotection by ischemic pre- and postconditioning [8, 15, 19, 21]. Calcium-induced MPTP opening occurred at lower calcium concentrations in STAT3-KO mitochondria than in WT mitochondria respiring on complex 1 only in the presence of ADP and MgCl2. The more pronounced MPTP opening of mitochondria respiring on complex 1 with ADP and MgCl2 compared to basal conditions was also confirmed in Stattic-treated rat mitochondria. Stattic enhanced calcium-induced MPTP opening already under basal conditions in rat mitochondria, but not in mouse STAT3-KO mitochondria. Such accelerated MPTP opening in STAT3-KO mitochondria, especially in the presence of ADP and MgCl2, may contribute to the loss of endogenous cardioprotection in STAT3-deficient mice. Whether or not the impact of STAT3 on MPTP opening is due to changes in the mitochondrial membrane potential is unknown at present.

The more pronounced effect of Stattic on respiration and MPTP opening compared to that of STAT3-KO mitochondria may be due to the fact that Stattic inhibits all STAT3-containing mitochondria, whereas in mitochondrial preparations from mice with a cardiomyocyte-specific deletion of STAT3, a certain amount of STAT3 containing mitochondria from endothelial cells, vascular smooth muscle cells or invading blood cells is still present.

STAT3 co-immunoprecipitated with cyclophilin D, a matrix protein which facilitates MPTP opening when bound to the inner mitochondrial membrane [9]. CsA prevents binding of cyclophilin D to the inner mitochondrial membrane, thereby delays MPTP opening and contributes to infarct size reduction after ischemia/reperfusion injury in animals [1, 16, 21, 40] and man [32]. In the present study, CsA delayed calcium-induced MPTP opening in isolated mitochondria; however, this delay was more pronounced in control mitochondria than in STAT3-KO or Stattic-treated mitochondria. Whereas these in vitro data might suggest that infarct size reduction by CsA in vivo might be more pronounced in WT than in STAT3-KO mice, the present study demonstrated in fact a similar infarct size reduction by CsA in both genotypes. The magnitude of infarct size reduction by CsA was comparable to that achieved by ischemic postconditioning in WT mice [2]. Therefore, inhibition of cyclophilin D by CsA appears to be rather downstream of STAT3 in the signaling cascade of cardioprotection, or STAT3 and CsA interaction with different domains of cyclophilin D. The reduction of reperfusion injury by maneuvers such as ischemic postconditioning is dependent on STAT3 [2, 22], whereas the reduction of reperfusion injury by inhibition of the STAT3 co-precipitating protein cyclophilin D is apparently downstream of STAT3.

Limitations

The detection of total and phosphorylated STAT1 and STAT3 in mitochondria by western blot analysis and confocal laser scan microscopy is dependent on the affinities of the respective antibodies towards their target epitopes. Therefore, an accurate quantification of the amounts of total mitochondrial STAT1 and STAT3 is not possible without using purified proteins as standard. Whereas our immunoprecipitation and confocal laser scan microscopy data suggest that the phosphorylation of STAT3 is more prominent at Ser727 than at Tyr705, we cannot quantify the ratio of serine over tyrosine phosphorylated mitochondrial STAT3. The STAT3 inhibitor Stattic has been described to block the phosphorylation of STAT3 at Tyr705, and we confirmed this result in isolated mitochondria. However, the phosphorylation of STAT3 at Ser727 also tended to be decreased by Stattic. We can therefore not distinguish whether the decreased APD-stimulated respiration and the enhanced calcium-induced MPTP opening in Stattic-treated mitochondria are due to the inhibition of the STAT3 phosphorylation at residue Ser727, Tyr705 or both. One could speculate that the enhanced calcium-induced MPTP opening in STAT3-deficient mitochondria would be paralleled by enhanced infarct size in STAT3 KO mice after ischemia/reperfusion injury in vivo. However, similar infarct sizes were measured in WT and STAT3 KO mice. In contrast to the unaltered infarct size with ischemia/reperfusion per se, endogenous cardioprotection by ischemic pre- and postconditioning was abolished in STAT3 KO mice. These findings suggest that STAT3 deficiency can be compensated during ischemia/reperfusion, but that these compensatory mechanisms are not sufficient to mediate endogenous cardioprotection by ischemic pre- and postconditioning.

Potential clinical relevance

The reduced mitochondrial STAT3 level in aged hearts may be important for the loss of cardioprotection in aged mice [2, 5, 6]. Apart from aging, STAT3 expression is decreased in rats with diabetes [13] and in patients with end-stage heart failure [33], pathophysiological conditions also associated with loss of endogenous cardioprotection. The targeting of STAT3 to the mitochondria promotes Ras-dependent oncogenic transformation [12]. However, the present data also point to beneficial roles of mitochondrial STAT3 for maintaining mitochondrial function and thereby enhancing cell survival. Mitochondrial STAT3 possibly contributes to cardioprotection by augmentation of ADP-stimulated respiration and inhibition of MPTP opening, but not through interaction with CsA binding to cyclophilin D. Our data suggest that patients with reduced contents of STAT3 would benefit from CsA therapy in acute myocardial infarction.

Taken together, STAT1 and STAT3 are localized in the matrix of cardiomyocyte mitochondria. Mitochondrial STAT3 stimulates respiration and inhibits calcium-induced MPTP opening, thereby potentially contributing to cardioprotection.

Acknowledgments

We thank Dr. Sabine Stahlhofen and Astrid Büchert, Elvira Ungefug, Ina Konietzka, Anita van de Sand, and Petra Gres for excellent technical assistance. K.B. (BO 2955/1-1) and G.H. (He1320/18-1) are recipients of grants from the Deutsche Forschungsgemeinschaft.

Conflict of interest None.

Appendix 1: Pharmacological inhibition of STAT3

To exclude acute toxic effects of Stattic (STAT3 inhibitory compund, 6-Nitrobenzo[b]thiophene 1,1-dioxide), mitochondrial NAD(P)H autofluorescence and membrane potential were measured of 0.5 mg/mL rat LV SSM. The effect of Stattic or DMSO as vehicle, respectively, on the mitochondrial NAD(P)H autofluorescence (excitation 340 nm, emission 460 nm) or membrane potential (10 nmol/L of the potentiometric dye rhodamine 123, excitation 503 nm; emission 535 nm) was measured at 25°C in incubation buffer [containing in mmol/L: 125 KCl, 10 Tris/MOPS (3-(N-(morpholino)propanesulfonic acid), 1.2 Pi/Tris, 1.2 MgCl2, 0.02 EGTA, 5 glutamate, 2.5 malate, pH 7.4] in a Cary Eclipse spectrophotometer (Varian, Mulgrave, Australia). The difference between the fluorescence intensity 1 min prior and 1 min after the addition of DMSO, 100 μmol/L Stattic or 200 μmol/L Stattic, respectively, was quantified. To induce collapse of the mitochondrial membrane potential, 100 nmol/L FCCP was added, and the fluorescence intensity was calculated 1 min after FCCP administration (n = 5).

Appendix 2: Confocal laser scan microscopy

For mitochondrial subfractionation, rat LV mitochondria were incubated in isolation buffer with 600 μmol/L digitonin for 10 min on ice. Mitochondria were collected by centrifugation and subsequently incubated with 150 mmol/L KCl for 10 min on ice. Again, mitochondria were collected by centrifugation and resuspended in phosphate-buffered saline (PBS). Subfractionation of mitochondria was performed, as previously described [36].

Purified rat, mouse WT, or STAT3-KO LV mitochondria (intact or treated with digitonin and KCl) were incubated with anti-STAT3 Tyr705, anti-STAT3 Ser727, anti-STAT3, anti-ATP synthase α, anti-cytochrome c, or anti-cyclophilin D antibodies for 1 h at 25°C with gentle agitation and, after washing, with the respective secondary antibodies. Mitochondria were mounted with Vectashield and were examined by confocal laser scan microscopy (LSM Pascal 5, Zeiss, Jena, Germany) at 630× magnification. For negative control, primary antibodies were omitted. Unless otherwise stated, about 20–30 mitochondria were analyzed from each individual experiment (see Figs. 9, ,10,10, ,11,11, ,1212).

Footnotes

S. Lecour, Cape Town, South Africa, served as guest editor for the manuscript and was responsible for all editorial decisions, including the selection of reviewers. The policy applies to all manuscripts with authors from the editor’s institution.

References

1. Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, Ovize M. Postconditioning inhibits mitochondrial permeability transition. Circulation. 2005;111:194–197. doi: 10.1161/01.CIR.0000151290.04952.3B. [PubMed] [Cross Ref]
2. Boengler K, Buechert A, Heinen Y, Roeskes C, Hilfiker-Kleiner D, Heusch G, Schulz R. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res. 2008;102:131–135. doi: 10.1161/CIRCRESAHA.107.164699. [PubMed] [Cross Ref]
3. Boengler K, Dodoni G, Rodriguez-Sinovas A, Cabestrero A, Ruiz-Maena M, Gres P, Konietzka I, Lopez-Iglesias C, García-Dorado D, Heusch G, Schulz R. Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res. 2005;67:234–244. doi: 10.1016/j.cardiores.2005.04.014. [PubMed] [Cross Ref]
4. Boengler K, Hilfiker-Kleiner D, Drexler H, Heusch G, Schulz R. The myocardial JAK/STAT pathway: from protection to failure. Pharmacol Therap. 2008;120:172–185. doi: 10.1016/j.pharmthera.2008.08.002. [PubMed] [Cross Ref]
5. Boengler K, Konietzka I, Buechert A, Heinen Y, Garcia-Dorado D, Heusch G, Schulz R. Loss of ischemic preconditioning’s cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43. Am J Physiol Heart Circ Physiol. 2007;292:H1764–H1769. doi: 10.1152/ajpheart.01071.2006. [PubMed] [Cross Ref]
6. Boengler K, Schulz R, Heusch G. Loss of cardioprotection with ageing. Cardiovasc Res. 2009;83:247–261. doi: 10.1093/cvr/cvp033. [PubMed] [Cross Ref]
7. Boengler K, Stahlhofen S, Sand A, Gres P, Ruiz-Meana M, Garcia-Dorado D, Heusch G, Schulz R. Presence of connexin 43 in subsarcolemmal but not in interfibrillar cardiomyocyte mitochondria. Basic Res Cardiol. 2009;104:141–147. doi: 10.1007/s00395-009-0007-5. [PubMed] [Cross Ref]
8. Cohen MV, Yang XM, Downey JM. Acidosis, oxygen, and interference with mitochondrial permeability transition pore formation in the early minutes of reperfusion are critical to postconditioning’s success. Basic Res Cardiol. 2008;103:464–471. doi: 10.1007/s00395-008-0737-9. [PMC free article] [PubMed] [Cross Ref]
9. Di Lisa F, Bernardi P. A CaPful of mechanisms regulating the mitochondrial permeability transition. J Mol Cell Cardiol. 2009;46:775–780. doi: 10.1016/j.yjmcc.2009.03.006. [PubMed] [Cross Ref]
10. Fuglesteg BN, Suleman N, Tiron C, Kanhema T, Lacerda L, Andreasen TV, Sack MN, Jonassen AK, Mjos OD, Opie LH, Lecour S. Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion. Basic Res Cardiol. 2008;103:444–453. doi: 10.1007/s00395-008-0728-x. [PMC free article] [PubMed] [Cross Ref]
11. Goodman MD, Koch SE, Fuller-Bicer GA, Butler KL. Regulating RISK: a role for JAK-STAT signaling in postconditioning? Am J Physiol Heart Circ Physiol. 2008;295:H1649–H1656. doi: 10.1152/ajpheart.00692.2008. [PubMed] [Cross Ref]
12. Gough DJ, Corlett A, Schlessinger K, Wegrzyn J, Larner AC, Levy DE. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science. 2009;324:1713–1716. doi: 10.1126/science.1171721. [PMC free article] [PubMed] [Cross Ref]
13. Gross ER, Hsu AK, Gross GJ. Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3 beta. Diabetes. 2007;56:127–136. doi: 10.2337/db06-0907. [PubMed] [Cross Ref]
14. Hattori R, Maulik N, Otani H, Zhu L, Cordis G, Engelman RM, Siddiqui MAQ, Das DK. Role of STAT3 in ischemic preconditioning. J Mol Cell Cardiol. 2001;33:1929–1936. doi: 10.1006/jmcc.2001.1456. [PubMed] [Cross Ref]
15. Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res. 2002;55:534–543. doi: 10.1016/S0008-6363(02)00455-8. [PubMed] [Cross Ref]
16. Hausenloy DJ, Yellon DM, Mani-Babu S, Duchen MR. Preconditioning protects by inhibiting the mitochondrial permeability transition. Am J Physiol Heart Circ Physiol. 2004;287:H841–H849. doi: 10.1152/ajpheart.00678.2003. [PubMed] [Cross Ref]
17. Heusch G. Nitroglycerin and delayed preconditioning in humans. Yet another new mechanism for an old drug? Circulation. 2001;103:2876–2878. [PubMed]
18. Heusch G, Boengler K, Schulz R. Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation. 2008;118:1915–1919. doi: 10.1161/CIRCULATIONAHA.108.805242. [PubMed] [Cross Ref]
19. Heusch G, Boengler K, Schulz R. Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection. Basic Res Cardiol. 2010;105:151–154. doi: 10.1007/s00395-009-0080-9. [PubMed] [Cross Ref]
20. Hilfiker-Kleiner D, Hilfiker A, Fuchs M, Kaminski K, Schaefer A, Schieffer B, Hillmer A, Schmiedl A, Ding Z, Podewski E, Poli V, Schneider MD, Schulz R, Park J-K, Wollert KC, Drexler H. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res. 2004;95:187–195. doi: 10.1161/01.RES.0000134921.50377.61. [PubMed] [Cross Ref]
21. Javadov SA, Clarke S, Das M, Griffiths EJ, Lim KH, Halestrap AP. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol. 2003;549:513–524. doi: 10.1113/jphysiol.2003.034231. [PubMed] [Cross Ref]
22. Lacerda L, Somers S, Opie HL, Lecour S. Ischemic postconditioning protects against reperfusion injury via the SAFE pathway. Cardiovasc Res. 2009;84:201–208. doi: 10.1093/cvr/cvp274. [PubMed] [Cross Ref]
23. Lecour S. Activation of the protective survivor activating factore enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK path? J Mol Cell Cardiol. 2009;47:32–40. doi: 10.1016/j.yjmcc.2009.03.019. [PubMed] [Cross Ref]
24. Lecour S, Suleman N, Deuchar GA, Somers S, Lacerda L, Huisamen B, Opie LH. Pharmacological preconditioning with tumor necrosis factor-a activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase) Circulation. 2005;112:3911–3918. doi: 10.1161/CIRCULATIONAHA.105.581058. [PubMed] [Cross Ref]
25. Levy DE, Lee CK. What does Stat3 do? J Clin Invest. 2002;109:1143–1148. [PMC free article] [PubMed]
26. Matsuyama N, Leavens JE, McKinnon D, Gaudette GR, Aksehirli TO, Krukenkamp IB. Ischemic but not pharmacological preconditioning requires protein synthesis. Circulation. 2000;102:312–318. [PubMed]
27. Myers MG. Moonlighting in mitochondria. Science. 2009;323:723–724. doi: 10.1126/science.1169660. [PubMed] [Cross Ref]
28. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, Heusch G, Vinten-Johansen J, Yellon DM, Schulz R. Postconditioning and protection from reperfusion injury: where do we stand? Cardiovasc Res. 2010;87:406–423. doi: 10.1093/cvr/cvq129. [PubMed] [Cross Ref]
29. Palmer JW, Tandler B, Hoppel CL. Biochemical properties of subsarcolemmal and inter-fibrillar mitochondria isolated from rat cardiac-muscle. J Biol Chem. 1977;252:8731–8739. [PubMed]
30. Pfeffer LM, Mullersman JE, Pfeffer SR, Murti A, Shi W, Yang CH. STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor. S. 1997;276:1418–1420. [PubMed]
31. Phillips D, Reilley MJ, Aponte AM, Wang G, Boja E, Gucek M, Balaban RS. Stoichiometry of STAT3 and mitochondrial proteins: implications for the regulation of oxidative phosphorylation by protein-protein interactions. J Biol Chem. 2010;285:23532–23536. doi: 10.1074/jbc.C110.152652. [PMC free article] [PubMed] [Cross Ref]
32. Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, Elbelghiti R, Cung TT, Bonnefoy E, Angoulvant D, Macia C, Raczka F, Sportouch C, Gahide G, Finet G, Andre-Fouet X, Revel D, Kirkorian G, Monassier J-P, Derumeaux G, Ovize M. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med. 2008;359:473–481. doi: 10.1056/NEJMoa071142. [PubMed] [Cross Ref]
33. Podewski EK, Hilfiker-Kleiner D, Hilfiker A, Morawietz H, Lichtenberg A, Wollert KC, Drexler H. Alterations in janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. Circulation. 2003;107:798–802. doi: 10.1161/01.CIR.0000057545.82749.FF. [PubMed] [Cross Ref]
34. Rasola A, Bernardi P. The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis. 2007;12:815–833. doi: 10.1007/s10495-007-0723-y. [PubMed] [Cross Ref]
35. Riva A, Tandler B, Loffredo F, Vazquez E, Hoppel C. Structural differences in two biochemically defined populations of cardiac mitochondria. Am J Physiol Heart Circ Physiol. 2005;289:H868–H872. doi: 10.1152/ajpheart.00866.2004. [PubMed] [Cross Ref]
36. Rodriguez-Sinovas A, Boengler K, Cabestrero A, Gres P, Morente M, Ruiz-Meana M, Konietzka I, Miró E, Totzeck A, Heusch G, Schulz R, Garcia-Dorado D. Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection. Circ Res. 2006;99:93–101. doi: 10.1161/01.RES.0000230315.56904.de. [PubMed] [Cross Ref]
37. Rottlaender D, Boengler K, Wolny M, Michels G, Endres-Becker J, Motloch LJ, Schwaiger A, Buechert A, Schulz R, Heusch G, Hoppe UC. Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes. J Clin Invest. 2010;120:1441–1453. doi: 10.1172/JCI40927. [PMC free article] [PubMed] [Cross Ref]
38. Rowland RT, Meng X, Cleveland JC, Jr, Meldrum DR, Harken AH, Brown JM. Cardioadaptation induced by cyclic ischemic preconditioning is mediated by translational regulation of de Novo protein synthesis. J Surg Res. 1997;71:155–160. doi: 10.1006/jsre.1997.5142. [PubMed] [Cross Ref]
39. Skyschally A, Schulz R, Heusch G. Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning. Herz. 2008;33:88–100. doi: 10.1007/s00059-008-3101-9. [PubMed] [Cross Ref]
40. Skyschally A, Schulz R, Heusch G. Cyclosporine A at reperfusion reduces infarct size in pigs. Cardiovasc Drugs Ther. 2010;24:85–87. doi: 10.1007/s10557-010-6219-y. [PMC free article] [PubMed] [Cross Ref]
41. Smith RM, Suleman N, Lacerda L, Opie LH, Akira S, Chien KR, Sack MN. Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning. Cardiovasc Res. 2004;63:611–616. doi: 10.1016/j.cardiores.2004.06.019. [PubMed] [Cross Ref]
42. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L’Huillier I, Aupetit J-F, Bonnefoy E, Finet G, Andre-Fouet X, Ovize M. Postconditioning the human heart. Ciculation. 2005;112:2143–2148. doi: 10.1161/CIRCULATIONAHA.105.558122. [PubMed] [Cross Ref]
43. Suleman N, Somers S, Smith R, Opie LH, Lecour SC. Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning. Cardiovasc Res. 2008;79:127–133. doi: 10.1093/cvr/cvn067. [PubMed] [Cross Ref]
44. Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, Koeck T, Derecka M, Szczepanek K, Szelag M, Gornicka A, Moh A, Moghaddas S, Chen Q, Bobbili S, Cichy J, Dulak J, Baker DP, Wolfman A, Stuehr D, Hassan MO, Fu XY, Avadhani N, Drake JI, Fawcett P, Lesnefsky EJ, Larner AC. Function of mitochondrial Stat3 in cellular respiration. Science. 2009;323:793–797. doi: 10.1126/science.1164551. [PMC free article] [PubMed] [Cross Ref]
45. Xuan Y-T, Guo Y, Han H, Zhu Y, Bolli R. An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci USA. 2001;98:9050–9055. doi: 10.1073/pnas.161283798. [PubMed] [Cross Ref]
46. Yamaura G, Turoczi T, Yamamoto F, Siddqui MA, Maulik N, Das DK. STAT signaling in ischemic heart: a role of STAT5A in ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285:H476–H482. [PubMed]

Articles from Springer Open Choice are provided here courtesy of Springer